Pioneering Equitable Biomarker Discovery
Traditional biomarker discovery often overlooks population diversity, leading to tools that may not perform equally well across different racial and ethnic groups. This disparity hinders progress in personalized medicine.
With 25+ Years of experience we provide in depth biomarker analysis using a wide collection of proven biomarkers tailored for survival analysis, therapeutic response and remission and reccurance markers.
Our team utilizes state-of-the-art (SOTA) computational approaches specifically designed to identify robust and reliable biomarkers while actively addressing potential biases related to ancestry and race. We integrate multi-omics data and employ advanced machine learning techniques.
